Dr. Andy Lewis, Chief Scientific Officer at Quotient Sciences, contributes to Pharma Source article on How to Build Resilient Pharma-CDMO Partnerships in 2025.
With the pharmaceutical sector facing geopolitical uncertainty, evolving regulations, and rapid technological change, defining what makes a strong external partnership has become more crucial than ever.
In this article the industry leaders from CDMOs, biotech firms, and technology providers for their perspectives on building partnerships that can withstand today’s and tomorrow’s challenges
Dr. Andy Lewis emphasizes that “the strongest partnerships are where there is both a cultural and commercial fit between the organizations. This not only aligns the team’s priorities from the outset, but also fosters open communication and an environment of trust and transparency.
Read the full article on the Pharma Source website.